“senescent cells senolytic”的搜索结果，显示 401-410 项，共有 10856 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Giving chemotherapy before a stem cell transplant helps kill cancer cells ... cells (stem cells) to grow. Stem cells removed prior to treatment are then ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Giving chemotherapy before a stem cell transplant helps kill cancer cells ... cells (stem cells) to grow. Stem cells removed prior to treatment are then ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The chimeric antigen receptor (CAR) T-cell therapy is a revolutionary cellular immunotherapy strategy that has transformed the treatment of B cell malignancies ...

5. 外科 - 临床试验- 妙佑医疗国际

   Allogeneic Mesenchymal Stromal Cell Donor Bank. Rochester, Minn. The purpose of this study is to collect adipose tissue from patients undergoing elective ...

6. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is evaluate the safety of allogeneic adipose derived mesenchymal stem cell (AMSC) use during hemodialysis arteriovenous fistula ...

7. 血液科- 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

8. 神经科- 临床试验- 妙佑医疗国际

   This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns of ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Giving chemotherapy before a stem cell transplant helps kill cancer cells ... cells (stem cells) to grow. Stem cells removed prior to treatment are then ...

10. 血液科- 临床试验- 妙佑医疗国际

    This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...